Send Message
Home News

company news about UNICEF provides HPV vaccine to 52 countries

China Hangzhou AllTest Biotech CO.,LTD certification
Customer Reviews
We recently started selling your HCG tests via our Australian partner and have been very impressed with the quality and consistency of the tests. They seem to be superior to our current manufacturer and we also know that you are far more reliable in terms of production times and communication.

—— One customer from Europe

We would like to explore the possibility of switching our HCG tests over to you. We have been reluctant in the past to move everything over to you as it makes us very reliant on you. However, we have always found you to be by far the most reliable of all our Chinese manufacturers and so we feel comfortable strengthening our partnership further

—— One customer from Europe

I like the products and service provided by AllTest. They really take our interest into consideration.

—— Mr John Smith England

My oldest daughter actually has Lyme disease. She spent almost 1 year in a wheelchair because of Lyme. She is doing very well now. I used 2 of the samples. 1 to test my Lyme diagnosed daughter and 1 to test my daughter who does not have Lyme. Your tests worked well. My daughter with Lyme tested positive and the one who does not tested negative.

—— Ms Sheila

Whenever I have the requests,AllTest always give me the satisfied reply at the first time.

—— Mrs Julie Tschetter Belgium

As the old customer of AllTest since 2009, we should thank the great work have been done by AllTest to support us gain more market share and profit

—— Mr Robin Seifert Germany

I'm Online Chat Now
Company News
UNICEF provides HPV vaccine to 52 countries
Latest company news about UNICEF provides HPV vaccine to 52 countries

UNICEF provides HPV vaccine to 52 countries


UNICEF recently announced that it will provide the human papillomavirus (HPV) vaccine to 52 countries. In 2023 alone, UNICEF will provide this life-saving vaccine to a quarter of the world's countries.


Seven countries - Bangladesh, Cambodia, Swatini, Kiribati, Mongolia, Nigeria and Togo - intend to include HPV vaccine in their routine immunization programs in 2023. On April 28, 2023, UNICEF confirmed that only one in eight girls has been vaccinated against HPV, the leading cause of cervical cancer. Since 2019, HPV vaccination coverage has declined by 15 percent, one of the largest regressions of any vaccine during the pandemic.


Oluwaseun Ayanniyi, a contract specialist at UNICEF's Vaccine Centre in the Supply Division in Copenhagen, commented that she is optimistic that significant progress can be made again in preventing cervical cancer.


The CDC says HPV vaccines can help prevent certain cancers in boys and girls. These vaccines are usually available at clinics and pharmacies in the United States. As of May 8, 2023, the FDA has approved a variety of vaccines that can prevent certain sexually transmitted diseases, such as Mpox.


Importance of Vaccination for Preventing HPV


Vaccination is a critical tool for preventing human papillomavirus (HPV) infection, which can lead to several types of cancer, including cervical cancer, anal cancer, and oropharyngeal cancer. The HPV vaccine is highly effective in preventing the types of HPV that cause most cases of cervical cancer and other HPV-related cancers.


The vaccine is recommended for both boys and girls, ideally before they become sexually active, as it is most effective when given before exposure to the virus. The World Health Organization recommends vaccinating girls aged 9-14 years with two doses of the HPV vaccine, while older girls and women may require three doses. Boys should also receive the HPV vaccine, as it can prevent HPV-related cancers in both sexes.


In addition to vaccination, regular cervical cancer screening is important for early detection and treatment of precancerous lesions. Vaccination and screening together can significantly reduce the incidence of cervical cancer. It is essential to continue to promote and prioritize HPV vaccination efforts to prevent HPV-related cancers and improve overall public health.

Pub Time : 2023-05-15 14:44:22 >> News list
Contact Details
Hangzhou AllTest Biotech CO.,LTD

Contact Person: Mrs. Selina

Tel: 86-13989889852

Send your inquiry directly to us (0 / 3000)